Trials / Terminated
TerminatedNCT02415010
Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms
A Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this Post-Market Clinical Follow-up (PMCF) is to confirm the performance and safety of the Codman Enterprise® 2 when used in conjunction with endovascular coil embolization of ruptured or non-ruptured intracranial aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Enterprise 2 Vascular Reconstruction Device | Stenting Assisted coiling procedure |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2019-06-25
- Completion
- 2019-06-25
- First posted
- 2015-04-14
- Last updated
- 2019-12-12
Locations
10 sites across 4 countries: Germany, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02415010. Inclusion in this directory is not an endorsement.